Finanzen von Proto Labs Inc (PRLB)PRLBProto Labs Inc

Proto Labs, Inc. (PRLB) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is C N C Machining Firstcut, accounting for 47.1% of total sales, equivalent to $70.36M. Other significant revenue streams include Injection Molding Protomold and Three D Printing Fineline. Understanding this composition is critical for investors evaluating how PRLB navigates market cycles within the Industrial Machinery & Equipment industry.

Evaluating the bottom line, Proto Labs, Inc. maintains a gross margin of 46.43%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 8.85%, while the net margin is 6.13%. These profitability ratios, combined with a Return on Equity (ROE) of 4.49%, provide a clear picture of how effectively PRLB converts its operational activities into shareholder value.

In the context of the broader market, PRLB competes directly with industry leaders such as GEL and STDN. With a market capitalization of $2.20B, it holds a significant position in the sector. When comparing efficiency, PRLB's gross margin of 46.43% stands against GEL's 20.20% and STDN's 67.21%. Such benchmarking helps identify whether Proto Labs, Inc. is trading at a premium or discount relative to its financial performance.

Proto Labs has shown consistent revenue growth, with Q2 2026 revenue at $149.3 million and a gross margin of 46.43%, indicating strong profitability. The net income for Q2 2026 was $9.15 million, further demonstrating financial health.